The Board & Executive Advisory team at Urovant Sciences provides strategic guidance and oversight to the company, ensuring alignment with its mission of innovating in urology. This team, composed of experienced advisors and board members, advises on corporate governance, key business decisions, and strategic initiatives, including the development and potential commercialization of vibegron (RVT-901).
View all